BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 21525170)

  • 1. Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats.
    Naud J; Michaud J; Beauchemin S; Hébert MJ; Roger M; Lefrancois S; Leblond FA; Pichette V
    Drug Metab Dispos; 2011 Aug; 39(8):1363-9. PubMed ID: 21525170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of intestinal drug transporters in chronic renal failure in rats.
    Naud J; Michaud J; Boisvert C; Desbiens K; Leblond FA; Mitchell A; Jones C; Bonnardeaux A; Pichette V
    J Pharmacol Exp Ther; 2007 Mar; 320(3):978-85. PubMed ID: 17135344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic renal failure on brain drug transporters in rats.
    Naud J; Laurin LP; Michaud J; Beauchemin S; Leblond FA; Pichette V
    Drug Metab Dispos; 2012 Jan; 40(1):39-46. PubMed ID: 21969519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic renal failure on liver drug transporters.
    Naud J; Michaud J; Leblond FA; Lefrancois S; Bonnardeaux A; Pichette V
    Drug Metab Dispos; 2008 Jan; 36(1):124-8. PubMed ID: 17940133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
    Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
    J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renal failure on drug transport and metabolism.
    Sun H; Frassetto L; Benet LZ
    Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased in vivo metabolism of drugs in chronic renal failure.
    Leblond FA; Giroux L; Villeneuve JP; Pichette V
    Drug Metab Dispos; 2000 Nov; 28(11):1317-20. PubMed ID: 11038159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of liver drug-metabolizing enzymes in a murine model of chronic renal failure.
    Dani M; Boisvert C; Michaud J; Naud J; Lefrançois S; Leblond FA; Pichette V
    Drug Metab Dispos; 2010 Mar; 38(3):357-60. PubMed ID: 20007296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators.
    Guévin C; Michaud J; Naud J; Leblond FA; Pichette V
    Br J Pharmacol; 2002 Dec; 137(7):1039-46. PubMed ID: 12429576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UT-A expression in pars recta from a rat model of chronic renal failure.
    Zotta E; Ochoa F; Tironi Farinati C; Damiano A; Silberstein C; Levy Yeyati N; Ibarra C
    J Nephrol; 2008; 21(6):947-58. PubMed ID: 19034881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450.
    Michaud J; Dubé P; Naud J; Leblond FA; Desbiens K; Bonnardeaux A; Pichette V
    Br J Pharmacol; 2005 Apr; 144(8):1067-77. PubMed ID: 15700027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of chronic renal failure on drug metabolism and transport.
    Dreisbach AW
    Clin Pharmacol Ther; 2009 Nov; 86(5):553-6. PubMed ID: 19776735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Chronic Renal Failure on Brain Cytochrome P450 in Rats.
    Naud J; Harding J; Lamarche C; Beauchemin S; Leblond FA; Pichette V
    Drug Metab Dispos; 2016 Aug; 44(8):1174-9. PubMed ID: 27271372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral sorbent AST-120 increases renal NO synthesis in uremic rats.
    Tumur Z; Niwa T
    J Ren Nutr; 2008 Jan; 18(1):60-4. PubMed ID: 18089446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
    Perri D; Ito S; Rowsell V; Shear NH
    Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure.
    Laouari D; Yang R; Veau C; Blanke I; Friedlander G
    Am J Physiol Renal Physiol; 2001 Apr; 280(4):F636-45. PubMed ID: 11249855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of indoxyl sulfate in OAT1/3-positive tubular cells in kidneys of patients with chronic renal failure.
    Taki K; Nakamura S; Miglinas M; Enomoto A; Niwa T
    J Ren Nutr; 2006 Jul; 16(3):199-203. PubMed ID: 16825019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules.
    Imaoka T; Kusuhara H; Adachi-Akahane S; Hasegawa M; Morita N; Endou H; Sugiyama Y
    J Am Soc Nephrol; 2004 Aug; 15(8):2012-22. PubMed ID: 15284287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats.
    Deguchi T; Takemoto M; Uehara N; Lindup WE; Suenaga A; Otagiri M
    J Pharmacol Exp Ther; 2005 Aug; 314(2):932-8. PubMed ID: 15879000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Messenger RNA for enzymes of ornithine and polyamine metabolism are selectively underexpressed in kidney of 5/6 nephrectomized rats.
    el-Marjou A; Bankir L; Pierrat D; Trinh-Trang-Tan MM
    Exp Nephrol; 1997; 5(4):285-94. PubMed ID: 9259182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.